Experience with Indium-111 and Yttrium-90-Labeled Somatostatin Analogs

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|8|20|1781-1807

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.20, 2002-09, pp. : 1781-1807

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zevalin TM: 90 Yttrium Labeled Anti-CD20 (Ibritumomab Tiuxetan), a New Treatment for Non-Hodgkin's Lymphoma

By  

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 4, 2001-12 ,pp. : 341-349

Bentham Science Publishers

Access to resources Recommend Favorite

Somatostatin and its Analogs

By  

Current Drug Targets, Vol. 17, Iss. 5, 2016-04 ,pp. : 529-537

Bentham Science Publishers

Access to resources Recommend Favorite

Osteonecrosis with yttrium-90 citrate

By  

Reactions Weekly, Vol. 1, Iss. 1355, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Preliminary Experience with Yttrium-90-labelled Rituximab (Chimeric Anti CD-20 Antibody) in Patients with Relapsed and Refractory B Cell Non-Hodgkins Lymphoma

By  

Current Radiopharmaceuticals, Vol. 9, Iss. 2, 2016-08 ,pp. : 160-168

Bentham Science Publishers

Access to resources Recommend Favorite

Yttrium-90: Gastroduodenal ulcer: case report

By  

Reactions Weekly, Vol. 1, Iss. 1418, 2012-01 ,pp. : 46-46

Adis International

Access to resources Recommend Favorite